Symptoms of Low Magnesium: Causes and Treatment
Deficiency
Symptoms & causes
Magnesium deficiency (hypomagnesemia) is one of the most prevalent nutritional shortfalls in the Western world — estimated to affect up to 45% of Americans — with real consequences for muscle cramps, sleep, blood pressure, insulin sensitivity, and cardiac rhythm; it is also one of the most practical nutritional interventions, with inexpensive supplements and consistent evidence across multiple health outcomes.
Magnesium deficiency is a genuine and widespread nutritional problem, not a wellness trend. Because standard blood tests miss most cases, many people live with symptoms like muscle cramps, poor sleep, and anxiety without knowing the cause. This guide covers the symptoms, causes, best supplement forms, and why people on GLP-1 medications face a uniquely high risk.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Magnesium — an essential macromineral and the fourth most abundant mineral in the body; approximately 50–60% stored in bone, ~40% in soft tissues and cells, <1% in blood. Functions as a cofactor in over 300 enzymatic reactions (energy metabolism, protein synthesis, DNA and RNA synthesis, cell signaling, muscle and nerve function, bone development, blood glucose regulation). Also the physiological antagonist of calcium in muscle contraction: calcium triggers contraction; magnesium enables relaxation. RDA: men 400–420 mg/day; women 310–320 mg/day; pregnancy: 350–360 mg/day. UL from supplemental magnesium (not dietary): 350 mg/day elemental magnesium from supplements only (excess causes osmotic diarrhea — the mechanism of magnesium citrate as a laxative). Rich food sources: pumpkin seeds (~156 mg per oz); dark chocolate (70–85% cocoa — ~64 mg per oz); black beans (~60 mg per 1/2 cup); edamame; almonds (~77 mg per oz); spinach (~78 mg per 1/2 cup cooked); avocado (~58 mg per whole avocado); brown rice, whole grains; salmon, halibut (~26–28 mg per 3 oz).
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Muscle cramps and spasms (most commonly calf cramps, particularly nocturnal; also foot cramps — one of the most common presenting complaints)
- Fatigue and weakness
- Difficulty sleeping (insomnia)
- Constipation
- Headaches and migraines (magnesium is involved in neurovascular regulation; migraine prevention with magnesium has substantial evidence)
- Anxiety and irritability
- Irregular heartbeat / palpitations (magnesium is critical for cardiac ion channel function — hypomagnesemia causes QT prolongation and predisposes to arrhythmias including torsades de pointes)
- Nausea
- In more severe deficiency: tetany (carpal-pedal spasm, Chvostek sign, Trousseau sign — shared with hypocalcemia because magnesium is required for PTH secretion and action)
- Seizures
- Severe arrhythmias
Don't wait
See a doctor if
- Cardiac palpitations or documented arrhythmias — magnesium status should be part of the workup; torsades de pointes is a potentially fatal arrhythmia triggered by hypomagnesemia; IV magnesium is the treatment of choice for torsades
- Tetany or seizures require emergency evaluation
- Recurrent muscle cramps with fatigue and insomnia warrant clinical assessment including serum magnesium (recognizing its limitations), dietary review, and evaluation for medications causing magnesium wasting
- Patients on loop diuretics (furosemide) or proton pump inhibitors (omeprazole, pantoprazole) should have periodic magnesium monitoring
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- People eating highly processed Western diets with low vegetable, nut, legume, and whole grain intake
- Older adults
- People with type 2 diabetes (extremely relevant GLP-1 population)
- People on loop diuretics or long-term PPIs
- People with GI malabsorption (Crohn's, celiac, short bowel syndrome)
- Chronic heavy alcohol users
- People with uncontrolled diabetes (osmotic diuresis)
- Patients on GLP-1 therapy with reduced dietary intake who are not eating magnesium-rich foods
What causes low Magnesium — an essential macromineral and the fourth most abundant mineral in the body; approximately 50–60% stored in bone, ~40% in soft tissues and cells, <1% in blood. Functions as a cofactor in over 300 enzymatic reactions (energy metabolism, protein synthesis, DNA and RNA synthesis, cell signaling, muscle and nerve function, bone development, blood glucose regulation). Also the physiological antagonist of calcium in muscle contraction: calcium triggers contraction; magnesium enables relaxation. RDA: men 400–420 mg/day; women 310–320 mg/day; pregnancy: 350–360 mg/day. UL from supplemental magnesium (not dietary): 350 mg/day elemental magnesium from supplements only (excess causes osmotic diarrhea — the mechanism of magnesium citrate as a laxative). Rich food sources: pumpkin seeds (~156 mg per oz); dark chocolate (70–85% cocoa — ~64 mg per oz); black beans (~60 mg per 1/2 cup); edamame; almonds (~77 mg per oz); spinach (~78 mg per 1/2 cup cooked); avocado (~58 mg per whole avocado); brown rice, whole grains; salmon, halibut (~26–28 mg per 3 oz).
- Inadequate dietary intake — the most common cause in the US; the modern Western diet (highly processed, refined grains, low in vegetables, legumes, and nuts) provides far less magnesium than whole-food diets; food processing (milling whole grains to white flour) removes up to 80% of magnesium
- Gastrointestinal losses — chronic diarrhea (Crohn's disease, celiac disease, short bowel syndrome); malabsorptive conditions; vomiting
- Medications — the two most clinically important: (a) loop diuretics (furosemide, bumetanide — increase renal magnesium excretion; hypomagnesemia is common in patients on loop diuretics); (b) proton pump inhibitors (PPIs) — the FDA issued a safety communication in 2011 warning that long-term PPI use (>1 year in most cases) can cause hypomagnesemia; mechanism: reduced intestinal magnesium absorption; other culprits: thiazide diuretics, aminoglycoside antibiotics, cisplatin, amphotericin B, cyclosporine
- Chronic alcohol use disorder — multiple mechanisms
- Type 2 diabetes (osmotic diuresis from hyperglycemia increases urinary magnesium excretion; also decreased intestinal absorption in T2DM)
- Older age — reduced intestinal absorption and increased renal excretion with age
How low levels are diagnosed
Serum magnesium — the standard clinical test; normal range approximately 1.7–2.2 mg/dL (0.7–0.9 mmol/L); critically: serum magnesium reflects only <1% of total body magnesium and is maintained at the expense of bone and soft tissue stores — it may be normal even with meaningful total-body depletion. RBC magnesium — better reflects intracellular status; not widely available clinically. 24-hour urinary magnesium — useful for distinguishing renal vs. intestinal causes of depletion; low urine Mg with hypomagnesemia = intestinal loss or inadequate intake; high urine Mg with hypomagnesemia = renal wasting. Magnesium loading test (IV magnesium with 24-hour urine collection) — reference standard for body magnesium status; rarely used clinically.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food sources: pumpkin seeds, dark chocolate, almonds, spinach, avocado, black beans, brown rice, salmon. The key message: processed food diets are severely depleted of magnesium — returning to whole foods substantially increases intake. Supplementation: multiple forms — (a) Magnesium citrate: well-absorbed, commonly causes loose stools at doses above 200–300 mg elemental Mg/day — useful if constipated; (b) Magnesium glycinate (bisglycinate): gentler on GI tract, good absorption, preferred for sleep and anxiety uses; (c) Magnesium oxide: poor bioavailability (~4%); commonly used in laxatives; least useful for nutritional repletion; (d) Magnesium malate: used for chronic fatigue and fibromyalgia protocols; (e) Magnesium threonate (MgT): claimed to cross the blood-brain barrier more effectively; preliminary animal data; limited human RCT evidence; (f) Topical/transdermal magnesium: theoretically absorbed through skin; clinical evidence is weak and absorption is minimal. Standard supplemental doses: 200–400 mg elemental magnesium/day in forms with good bioavailability (citrate, glycinate, malate); the supplement UL is 350 mg/day from supplements.
How to keep levels up
Whole food diet emphasizing magnesium-rich foods (seeds, nuts, dark chocolate, legumes, leafy greens, whole grains). Avoid prolonged use of medications that cause magnesium wasting when alternatives exist. For patients on long-term PPIs or loop diuretics: periodic serum magnesium monitoring; consider supplementation if below 1.8 mg/dL or symptomatic. Daily magnesium glycinate 200–400 mg is a reasonable precaution for adults eating processed diets, people on GLP-1 therapy, adults over 65, and people with type 2 diabetes.
When to see a clinician
Cardiac palpitations, arrhythmias, or ECG changes; tetany (muscle spasms, positive Chvostek/Trousseau signs); seizures; severe or prolonged vomiting/diarrhea causing significant losses; patients on loop diuretics, long-term PPIs, or cisplatin should have serum magnesium monitored regularly.
Magnesium Deficiency Is Not a Wellness Trend — It Is a Genuine and Measurable Nutritional Crisis
Up to 45–68% of Americans don't meet the Estimated Average Requirement (EAR) for magnesium from diet alone. This is not a fringe problem — it is a population-level nutritional deficit driven by the wholesale shift from whole foods to highly processed diets over the past century.
The mechanism is straightforward: milling whole grains into white flour strips away roughly 80% of the magnesium content. When you combine refined grains with low vegetable, nut, and legume intake — the defining pattern of the modern Western diet — you get a food supply that is structurally incapable of delivering adequate magnesium to most people.
What makes magnesium deficiency uniquely dangerous is how hard it is to detect. Serum magnesium, the standard blood test, reflects less than 1% of your total body magnesium. The body maintains serum levels homeostatically by pulling magnesium from bone and soft tissue reserves. A normal serum magnesium result does not rule out clinically meaningful depletion — your cells and bones can be running on empty while your bloodwork looks fine.
The consequences of population-level suboptimal magnesium are not subtle. Large observational studies consistently link low magnesium intake to higher rates of hypertension, type 2 diabetes progression, osteoporosis, and cardiovascular disease. Each of these conditions has a body of mechanistic evidence showing magnesium's direct involvement: magnesium regulates vascular tone, is required for insulin receptor signaling, stabilizes bone mineral matrix, and controls cardiac ion channels. This is not supplement-industry hype — magnesium has been in clinical use for decades, from IV magnesium for eclampsia in obstetrics to magnesium sulfate for torsades de pointes in cardiology, giving it a clinical evidence base that most 'wellness supplements' lack entirely.
Bottom line
Magnesium deficiency affects nearly half of Americans due to dietary shifts away from whole foods — and serum magnesium tests are poor at detecting it; this gives magnesium one of the most compelling cases in nutrition for widespread supplementation in at-risk groups.
Muscle Cramps, Sleep, Migraines, and Anxiety: The Clinical Evidence for Magnesium's Most Common Symptom Applications
Magnesium's role in muscle function is one of the most direct in nutrition: calcium triggers muscle contraction, and magnesium enables relaxation. When intracellular magnesium runs low, muscles struggle to fully relax — which is why nocturnal calf cramps are often the first symptom people notice.
The evidence for magnesium and muscle cramps is mixed but instructive. Cochrane reviews find the overall evidence for leg cramp treatment inconclusive, but pregnancy-associated leg cramps respond more clearly to magnesium supplementation. Clinically, many physicians observe that magnesium-deficient patients with cramps improve with repletion — the inconsistency in trials likely reflects the failure to select for deficient participants rather than a failure of magnesium itself.
Sleep is where magnesium's evidence is strongest. Several small randomized controlled trials, particularly in older adults, show that magnesium supplementation — typically 200–500 mg of magnesium glycinate or citrate before bed — improves sleep quality, reduces the time it takes to fall asleep, and decreases early morning awakening. Magnesium activates the parasympathetic nervous system and is involved in melatonin regulation, providing a plausible mechanism beyond simple muscle relaxation.
For migraine prevention, the American Headache Society includes magnesium supplementation (400–600 mg/day elemental magnesium) as a reasonable preventive option, especially for menstrual migraines. The best evidence supports its use in people with demonstrated magnesium deficiency, where repletion reduces migraine frequency meaningfully.
Anxiety is another domain where magnesium shows promise. Magnesium modulates the NMDA receptor and the hypothalamic-pituitary-adrenal (HPA) axis — both central to stress responses. A 2017 meta-analysis found that magnesium supplementation produced a modest but real anxiolytic effect in people with mild-to-moderate anxiety, particularly those with low baseline magnesium status.
Constipation relief is the one application where the mechanism is purely physical rather than nutritional: magnesium oxide and magnesium citrate at higher doses draw water into the bowel osmotically, acting as effective laxatives. This is a pharmacological effect, not a nutritional correction — and it is why lower doses of well-absorbed forms like glycinate do not cause diarrhea.
Bottom line
Magnesium has the strongest evidence base among common minerals for sleep improvement, migraine prevention, and anxiety reduction — particularly in deficient individuals; the evidence is moderate rather than definitive, but superior to most supplement categories.
Magnesium and Type 2 Diabetes: Insulin Sensitivity, GLP-1 Patients, and the PPI Warning
Magnesium is required for insulin receptor tyrosine kinase signaling — the very first step in insulin's cellular action. When intracellular magnesium is low, insulin receptors don't fire properly, and glucose metabolism suffers. This is not a minor biochemical footnote; it is a direct, well-characterized mechanism that explains why low magnesium status and type 2 diabetes are so tightly linked.
Prospective cohort studies consistently show that each 100 mg/day increase in magnesium intake is associated with an approximately 8–13% lower risk of developing type 2 diabetes. On the treatment side, randomized trials in magnesium-deficient T2DM patients show that supplementation modestly but consistently improves fasting glucose and HbA1c. The effect is not large enough to replace medication, but it is real and additive to standard care.
The PPI interaction is critically relevant to GLP-1 patients and is systematically under-discussed. Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole) are widely prescribed for GERD — a condition commonly worsened during early GLP-1 therapy by nausea and delayed gastric emptying. In 2011, the FDA issued a safety communication warning that long-term PPI use (greater than one year) can cause symptomatic hypomagnesemia severe enough to require IV magnesium and PPI discontinuation. The mechanism is reduced intestinal magnesium absorption. Any GLP-1 patient on chronic PPI therapy should have serum magnesium monitored periodically.
Loop diuretics (furosemide, bumetanide) present a parallel risk. These are commonly prescribed for heart failure and hypertension in the same cardiovascular-risk population that uses GLP-1 medications. Loop diuretics directly increase renal magnesium excretion, and clinically significant hypomagnesemia is common in patients on chronic furosemide — most will require supplementation.
Magnesium's glucose-lowering action via insulin sensitization is complementary to GLP-1 therapy, not a substitute for it. GLP-1 agonists work primarily through incretin pathways, gastric emptying, and central appetite suppression; magnesium works through intracellular insulin signaling. The two mechanisms are additive, and maintaining adequate magnesium status supports the metabolic improvements that GLP-1 therapy aims to achieve.
Bottom line
Type 2 diabetes impairs magnesium status (osmotic diuresis wastes magnesium), and magnesium deficiency impairs insulin signaling — this bidirectional relationship makes magnesium supplementation especially relevant for GLP-1 therapy patients with T2DM; PPI and loop diuretic use in this population further worsens magnesium status.
Supplement Form Guide: Why Magnesium Oxide Is a Waste of Money and What to Buy Instead
Walk into any pharmacy and the cheapest, most common magnesium supplement you will find is magnesium oxide. It is in virtually every low-cost multivitamin and marketed as a magnesium source. It is also nearly useless for correcting a nutritional deficiency — with bioavailability estimated at roughly 4%.
Magnesium oxide's high elemental magnesium content (~60% by weight) looks impressive on a label, but almost none of it actually enters your bloodstream. It passes through the GI tract largely unabsorbed, which is why it works as an osmotic laxative — it pulls water into the bowel and triggers a bowel movement. For constipation, that is useful. For repleting magnesium stores, it is a waste of money.
Magnesium citrate sits in the middle of the spectrum: well-absorbed (~16% elemental magnesium by weight) but with a predictable GI side effect. At doses above 200–300 mg of elemental magnesium, citrate reliably causes loose stools. This makes it the right choice if you are managing constipation and want magnesium repletion simultaneously, but a poor choice if you are taking magnesium for sleep or anxiety and want to avoid bathroom urgency.
Magnesium glycinate (bisglycinate) is the form most clinicians recommend for nutritional repletion, sleep, and anxiety. It is magnesium chelated to the amino acid glycine, which has its own calming neurotransmitter properties. Glycinate is well-absorbed, gentle on the GI tract, and does not cause diarrhea at standard supplemental doses (200–400 mg elemental magnesium/day). For most people, this is the best all-purpose magnesium supplement.
Magnesium malate (magnesium bound to malic acid) is similarly gentle and well-absorbed. Malic acid is a substrate in the citric acid cycle — the core energy-production pathway in mitochondria — which is why malate is often recommended in fibromyalgia and chronic fatigue protocols. The evidence for malate specifically over glycinate is limited, but it is a reasonable alternative for people who do not tolerate glycinate.
Magnesium threonate (MgT) is a proprietary, expensive form marketed on the claim that it crosses the blood-brain barrier more effectively than other magnesium compounds. Preliminary animal data support this idea, but human RCT evidence is thin, and the cost is substantially higher than glycinate or malate. It may have a role in cognitive applications, but for general deficiency repletion, sleep, or muscle cramps, the evidence does not justify the price premium.
Topical magnesium — Epsom salt baths, magnesium oils, and lotions — deserves a reality check. The clinical evidence for transdermal magnesium absorption is weak, and systematic reviews find minimal absorption through intact skin. A warm Epsom salt bath may relax muscles through heat and ritual, but it should not be relied upon to correct a magnesium deficiency.
- Magnesium glycinate: best for sleep, anxiety, muscle cramps — gentle on stomach
- Magnesium malate: good alternative to glycinate — often used for fatigue/fibromyalgia
- Magnesium citrate: well-absorbed but causes loose stools — best for constipation
- Magnesium oxide: ~4% absorption — useful only as a laxative, not for repletion
- Magnesium threonate: expensive, limited human data — possible cognitive applications
- Topical/transdermal: weak absorption evidence — do not rely on for deficiency
Bottom line
Magnesium glycinate and malate are the best-absorbed, GI-gentlest forms for nutritional repletion and sleep/anxiety applications; magnesium oxide (the most common form in cheap supplements) has ~4% bioavailability and is essentially useless for correcting deficiency.
Magnesium and GLP-1 Therapy: The Trifecta of Deficiency Risk and the Safe Supplementation Strategy
GLP-1 therapy patients — particularly those on semaglutide or tirzepatide for type 2 diabetes — face a triple threat to magnesium status that is rarely discussed as a unified risk. The first mechanism is straightforward: reduced food intake means less dietary magnesium from whole foods. When you eat less, you consume less of everything, including the magnesium-rich seeds, nuts, legumes, and leafy greens that are already scarce in most American diets.
The second mechanism is specific to type 2 diabetes, the most common indication for GLP-1 therapy. Hyperglycemia causes osmotic diuresis — the kidneys flush out excess glucose, and magnesium goes with it. This means that even before starting a GLP-1 medication, many T2DM patients are already magnesium-depleted from urinary losses alone.
The third mechanism is iatrogenic: the medications commonly prescribed alongside GLP-1 therapy. PPIs for GERD (which GLP-1 medications can worsen through delayed gastric emptying and nausea) reduce intestinal magnesium absorption — the FDA's 2011 warning on this is explicit and evidence-based. Loop diuretics for heart failure or hypertension directly increase renal magnesium excretion. A GLP-1 patient with T2DM who is also on a PPI and a loop diuretic — a common combination in this population — faces additive magnesium depletion from three independent pathways.
The good news is that magnesium supplementation is safe, inexpensive, and well-studied in this context. Magnesium glycinate 200–400 mg/day provides meaningful repletion without exceeding the supplemental UL of 350 mg/day elemental magnesium. There is no known pharmacokinetic interaction between magnesium and semaglutide or tirzepatide — they do not compete for absorption or metabolism in ways that would reduce the effectiveness of either.
Magnesium also offers complementary benefits that align with GLP-1 therapy goals. Meta-analyses show magnesium supplementation lowers systolic blood pressure by approximately 2–3 mmHg — a modest but real effect that adds to GLP-1 medications' own cardiovascular-protective properties. Magnesium's insulin-sensitizing action supports the glucose-lowering effects of GLP-1 therapy through a completely different mechanism. And maintaining adequate magnesium reduces arrhythmia risk in a population already at elevated cardiovascular risk.
The practical recommendation is straightforward: baseline serum magnesium measurement for GLP-1 patients — especially those on PPIs, loop diuretics, or with poorly controlled T2DM — followed by magnesium glycinate 200–400 mg/day as a reasonable, safe adjunct. This is not a substitute for prescribed GLP-1 therapy; it is a nutritional foundation that supports the metabolic improvements GLP-1 medications are designed to achieve.
Bottom line
GLP-1 patients with T2DM who are also on PPIs and/or loop diuretics face triple magnesium depletion risk — daily magnesium glycinate 200–400 mg is a practical, inexpensive, and well-supported intervention for this population.
What most pages leave out
Magnesium supplement marketing overstates the RCT evidence for most applications while underselling the critical pharmaceutical safety interactions (PPI-induced hypomagnesemia FDA warning; loop diuretic magnesium wasting; and the laxative vs. repletion distinction between supplement forms). The form guide — establishing that magnesium oxide (the most common form in cheap supplements) has ~4% bioavailability — is systematically absent from supplement content. Competitor content also fails to distinguish serum magnesium's limitations as a diagnostic test.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
Muscle cramps (especially nocturnal calf cramps), insomnia, headaches/migraines, anxiety, constipation, fatigue, and heart palpitations are the most common symptoms. In severe deficiency, tetany (muscle spasms), arrhythmias including potentially fatal torsades de pointes, and seizures can occur.
Magnesium glycinate (bisglycinate) is the best all-purpose form for sleep, anxiety, and muscle cramps — it is well absorbed and gentle on the GI tract. Magnesium citrate is a good choice if you also need constipation relief. Avoid magnesium oxide for nutritional deficiency; it has only ~4% bioavailability and is essentially useful only as a laxative.
Yes — the FDA issued a 2011 safety warning that long-term PPI use (greater than one year) can cause symptomatic hypomagnesemia. The mechanism is reduced intestinal magnesium absorption. Patients on chronic PPIs should have serum magnesium monitored periodically.
Several small randomized controlled trials, particularly in older adults, show that magnesium supplementation improves sleep quality, reduces the time to fall asleep, and decreases early morning awakening. Magnesium glycinate or malate at 200–400 mg/day before bed is the most commonly studied approach.
Magnesium is required for insulin receptor signaling, and deficiency impairs insulin action. Supplementation in T2DM patients with low magnesium modestly improves fasting glucose and HbA1c in randomized trials. Large prospective studies also show that higher dietary magnesium intake is associated with lower type 2 diabetes risk.
The Upper Limit (UL) for supplemental magnesium is 350 mg/day of elemental magnesium from supplements — dietary magnesium from food does not count toward this limit. Excess supplemental magnesium causes osmotic diarrhea. Higher doses require clinical supervision.
Serum magnesium represents less than 1% of total body magnesium and is homeostatically regulated. The body maintains serum levels by pulling magnesium from bone and soft tissue stores, so a normal serum result does not rule out clinically meaningful intracellular or total-body depletion.
GLP-1 patients with T2DM, on PPIs, or on loop diuretics have additive magnesium depletion risk. Magnesium glycinate 200–400 mg/day is a reasonable and safe adjunct. Discuss with your prescribing clinician and have baseline serum magnesium measured if you are on high-risk medications.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Is ZMA (Zinc Magnesium Aspartate) Good? Nutrition & Benefits
Honest ZMA review: does it boost testosterone or just correct deficiency? Evidence, nausea risks, GLP-1 safety, and better alternatives explained.
Read moreWhat Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrient—no deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isn’t a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient — no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.